DailyStocks Stock Article Search

https://seekingalpha.com/article/4666216-stryker-corporation-syk-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Jan 30, 2024 - Stryker Corporation (NYSE:NYSE:SYK) Q4 2023 Earnings Conference Call January 30, 2024 4:30 PM ETCompany ParticipantsKevin Lobo – Chair and Chief Executive... 0

https://www.zacks.com/stock/news/2199509/hae-vs-syk-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2199509 Dec 18, 2023 - HAE vs. SYK: Which Stock Is the Better Value Option? 0

https://www.zacks.com/stock/news/2204574/will-stryker-syk-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2204574 Jan 02, 2024 - Stryker (SYK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 0

https://www.zacks.com/stock/news/2205154/hae-or-syk-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2205154 Jan 03, 2024 - HAE vs. SYK: Which Stock Is the Better Value Option? 0

https://www.zacks.com/stock/news/2218369/stryker-syk-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2218369 Jan 30, 2024 - The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.zacks.com/stock/news/2222702/cvs-health-cvs-q4-earnings-top-estimates-2024-eps-view-down?cid=CS-ZC-FT-analyst_blog|earnings_article-2222702 Feb 07, 2024 - Robust sales growth across all three operating segments contributes to CVS Health's (CVS) Q4 revenues. 0

https://www.zacks.com/stock/news/2227054/here-s-why-you-should-retain-idexx-idxx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227054 Feb 15, 2024 - Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance 0

https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766 Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices. 0

https://www.zacks.com/stock/news/2228631/illumina-ilmn-rides-on-ngs-portfolio-expansion-amid-macro-woe?cid=CS-ZC-FT-analyst_blog|zer_report_update-2228631 Feb 20, 2024 - In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally. 0

https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2228769 Feb 20, 2024 - Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies. 0